Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENRES: Genetics of Drug Responsiveness in Essential Hypertension
NCT03276598Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Nov 1999
- Primary completion
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of amlodipine, bisoprolol, hydrochlorothiazide, losartan in essential hypertension, sponsored by Helsinki University Hospital. Started Nov 1999; status: completed.
02
Drugs
amlodipinebisoprololhydrochlorothiazidelosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT03276598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03276598.